Ayala Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ayala Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$8.78M, a 9.72% increase year-over-year.
  • Ayala Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$36.3M, a 3.3% increase year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$36.3M, a 3.3% increase from 2022.
  • Ayala Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$37.5M, a 99.6% decline from 2021.
  • Ayala Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$18.8M, a 29% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$36.3M -$8.78M +$945K +9.72% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$37.2M -$7.13M +$2.95M +29.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$40.2M -$8.49M -$634K -8.07% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$39.5M -$11.9M -$2.02M -20.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-23
Q4 2022 -$37.5M -$9.73M -$5.56M -134% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$31.9M -$10.1M -$5.71M -131% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$26.2M -$7.85M -$3.72M -90.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$22.5M -$9.85M -$3.53M -55.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-23
Q4 2021 -$19M -$4.16M -$201K -5.07% Nov 1, 2021 Jan 31, 2022 10-Q 2022-03-17
Q3 2021 -$18.8M -$4.37M +$2.03M +31.7% Aug 1, 2021 Oct 31, 2021 10-K 2023-02-10
Q2 2021 -$20.8M -$4.13M +$1.71M +29.3% May 1, 2021 Jul 31, 2021 10-Q 2022-09-13
Q1 2021 -$22.5M -$6.32M $0 0% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-08
Q4 2020 -$22.5M -$3.96M +$3.92M +49.7% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q3 2020 -$26.4M -$6.4M +$3.89M +37.8% Aug 1, 2020 Oct 31, 2020 10-K 2022-02-14
Q2 2020 -$30.3M -$5.84M +$4.29M +42.3% May 1, 2020 Jul 31, 2020 10-Q 2021-09-10
Q1 2020 -$34.6M -$6.32M +$1.55M +19.7% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2019 -$36.2M -$7.89M -$18.2M -176% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-16
Q3 2019 -$18M -$10.3M +$11.8M +53.5% Aug 1, 2019 Oct 31, 2019 10-K 2021-01-22
Q2 2019 -$29.8M -$10.1M +$4.03M +28.5% May 1, 2019 Jul 31, 2019 10-Q 2020-09-10
Q1 2019 -$33.8M -$7.87M +$5.68M +41.9% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-11
Q4 2018 -$39.5M $10.3M +$30.9M Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-13
Q3 2018 -$70.4M -$22.1M +$5.75M +20.6% Aug 1, 2018 Oct 31, 2018 10-K 2019-12-20
Q2 2018 -$76.1M -$14.2M +$18.6M +56.7% May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q1 2018 -$94.7M -$13.6M +$7.11M +34.4% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-10
Q4 2017 -$102M -$20.5M -$3.36M -19.6% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-12
Q3 2017 -$98.4M -$27.9M -$3.48M -14.3% Aug 1, 2017 Oct 31, 2017 10-K 2019-01-11
Q2 2017 -$95M -$32.7M -$16.2M -97.6% May 1, 2017 Jul 31, 2017 10-Q 2018-09-10
Q1 2017 -$78.8M -$20.7M -$5.07M -32.5% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-07
Q4 2016 -$73.7M -$17.2M +$2.77M +13.9% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-12
Q3 2016 -$76.5M -$24.4M -$9.93M -68.7% Aug 1, 2016 Oct 31, 2016 10-K 2017-12-21
Q2 2016 -$66.6M -$16.6M -$2.94M -21.5% May 1, 2016 Jul 31, 2016 10-Q 2017-09-11
Q1 2016 -$63.6M -$15.6M -$1.75M -12.7% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-06
Q4 2015 -$61.9M -$20M -$13.2M -194% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-10
Q3 2015 -$48.7M -$14.5M -$9.47M -190% Aug 1, 2015 Oct 31, 2015 10-K 2017-12-21
Q2 2015 -$39.2M -$13.6M -$7.63M -127% May 1, 2015 Jul 31, 2015 10-Q 2016-09-08
Q1 2015 -$31.6M -$13.8M -$11.2M -433% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 -$20.4M -$6.78M -$818K -13.7% Nov 1, 2014 Jan 31, 2015 10-Q 2016-02-26
Q3 2014 -$19.5M -$4.99M -$1M -25.2% Aug 1, 2014 Oct 31, 2014 10-K 2017-01-09
Q2 2014 -$18.5M -$6M -$2.95M -96.5% May 1, 2014 Jul 31, 2014 10-Q 2015-09-11
Q1 2014 -$15.6M -$2.6M +$2.88M +52.6% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-15
Q4 2013 -$18.5M -$5.96M -$3.78M -173% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-13
Q3 2013 -$14.7M -$3.98M -$1.7M -74.8% Aug 1, 2013 Oct 31, 2013 10-K 2015-01-06
Q2 2013 -$13M -$3.05M +$530K +14.8% May 1, 2013 Jul 31, 2013 10-Q 2014-09-09
Q1 2013 -$13.5M -$5.48M -$2.25M -69.6% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-10
Q4 2012 -$11.3M -$2.18M +$1.06M +32.8% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$12.3M -$2.28M +$767K +25.2% Aug 1, 2012 Oct 31, 2012 10-K 2014-01-29
Q2 2012 -$13.1M -$3.58M +$13.7K +0.38% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 -$13.1M -$3.23M +$179K +5.24% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 -$13.3M -$3.24M -$275K -9.25% Nov 1, 2011 Jan 31, 2012 10-Q/A 2013-03-25
Q3 2011 -$13M -$3.04M Aug 1, 2011 Oct 31, 2011 10-K/A 2013-02-14
Q2 2011 -$3.6M -$1.8M -99.8% May 1, 2011 Jul 31, 2011 10-Q/A 2012-10-04
Q1 2011 -$3.41M Feb 1, 2011 Apr 30, 2011 10-Q/A 2012-10-18
Q4 2010 -$2.97M Nov 1, 2010 Jan 31, 2011 10-Q/A 2012-10-18
Q2 2010 -$1.8M May 1, 2010 Jul 31, 2010 10-Q 2011-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.